Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213).
Authors:
- N I NissenNNN I Nissen
- V LarsenVLV Larsen
- H PedersenHPH Pedersen
- K ThomsenKTK Thomsen
- 1 December 1972
- journal article
- clinical trial
- Vol. 56 (6) , 769-77